INFLIXIMAB

219746 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 39960
1 OFF LABEL USE 39684
2 CONDITION AGGRAVATED 20035
3 INFUSION RELATED REACTION 19272
4 PAIN 18754
5 RHEUMATOID ARTHRITIS 18635
6 ARTHRALGIA 17973
7 FATIGUE 16917
8 PRODUCT USE ISSUE 13576
9 RASH 13516
See all common reactions for INFLIXIMAB

INFLIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 309 0.9196
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5784 0.8065
2 RED BLOOD CELL SEDIMENTATION RATE 219 0.7849
3 RHEUMATOID FACTOR POSITIVE 4149 0.7176
4 SWOLLEN JOINT COUNT INCREASED 2272 0.7118
5 PEMPHIGUS 8898 0.7110
6 RHEUMATIC FEVER 3100 0.6948
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 444 0.6647
8 GRANULOMA SKIN 530 0.6456
9 DUODENAL ULCER PERFORATION 4779 0.6420
See all enriched reactions for INFLIXIMAB